RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,728,000 | -23.5% | 800,000 | +14.3% | 0.93% | -14.5% |
| Q2 2023 | $8,792,000 | -30.7% | 700,000 | -9.1% | 1.09% | -57.4% |
| Q1 2023 | $12,681,900 | +35.8% | 770,000 | +23.2% | 2.56% | +30.4% |
| Q4 2022 | $9,337,500 | -30.4% | 625,000 | +4.2% | 1.96% | -24.8% |
| Q3 2022 | $13,422,000 | +83.7% | 600,000 | +37.5% | 2.61% | +73.5% |
| Q2 2022 | $7,307,000 | -25.3% | 436,262 | +33.4% | 1.50% | -41.0% |
| Q1 2022 | $9,787,000 | +41.6% | 327,000 | +45.3% | 2.55% | +33.2% |
| Q4 2021 | $6,910,000 | +56.5% | 225,000 | +60.7% | 1.91% | +50.7% |
| Q3 2021 | $4,414,000 | +0.5% | 140,000 | +16.7% | 1.27% | +5.0% |
| Q2 2021 | $4,391,000 | +111.7% | 120,000 | +100.0% | 1.21% | +103.9% |
| Q1 2021 | $2,074,000 | – | 60,000 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |